Insider Trading & Ownership - NKGEN BIOTECH INC WT EXP 05/31 (NKGNW)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for NKGEN BIOTECH INC WT EXP 05/31
Goto 0, 1, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-12-06
Purchase
2023-12-07
5:23 pm
NKGen Biotech Inc. NKGN Song Paul Y.
Chief Executive Officer
151 $3.3049 $500 171,121
(Direct)
View
2023-12-04
Purchase
2023-12-05
3:51 pm
NKGen Biotech Inc. NKGN Song Paul Y.
Chief Executive Officer
268 $3.172 $850 170,969
(Direct)
View
2023-12-01
Purchase
2023-12-05
3:50 pm
NKGen Biotech Inc. NKGN Graf James A
Graf Acquisition Partners IV LLC
Interim CFO
670 $3.2425 $2,173 2,437,437
(Indirect
Direct)
View
2023-11-27
Purchase
2023-11-28
4:10 pm
NKGen Biotech Inc. NKGN Song Paul Y.
Chief Executive Officer
244 $2.8754 $701 170,701
(Direct)
View
2023-11-20
Purchase
2023-11-22
5:55 pm
NKGen Biotech Inc. NKGN Graf James A
Graf Acquisition Partners IV LLC
Interim CFO
23 $2.9259 $67 2,436,767
(Indirect
Direct)
View
2023-11-21
Purchase
2023-11-22
5:53 pm
NKGen Biotech Inc. NKGN Song Paul Y.
Chief Executive Officer
153 $2.8172 $430 170,458
(Direct)
View
2021-05-28
Purchase
2021-06-03
06:03 am
Graf Acquisition Corp. IV GFOR Graf James A
Chief Executive Officer
5,000 $9.9 $49,500 4,237,175
(Direct)
View
2021-05-25
Purchase
2021-05-27
4:57 pm
Graf Acquisition Corp. IV GFOR Graf James A
Chief Executive Officer
500 $9.9192 $4,960 4,254,300
(Direct)
View
2021-05-25
Purchase
2021-05-26
9:05 pm
Graf Acquisition Corp. IV GFOR Garcia Gus
Co-President
1,500 $9.924 $14,886 1,500
(Direct)
View
2021-05-21
Purchase
2021-05-25
7:45 pm
Graf Acquisition Corp. IV GFOR Graf James A
Chief Executive Officer
1,300 $9.9412 $12,924 8,506,300
(Indirect
Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-12-20
Other
2024-12-26
7:20 pm
N/A
N/A
NKGen Biotech Inc. NKGN Graf Acquisition Partners IV LLC
Graf James A
10% Owner
63,634 $0 3,388,444
(Direct)
View
2024-12-02
Other
2024-12-23
4:01 pm
N/A
N/A
NKGen Biotech Inc. NKGN Graf Acquisition Partners IV LLC
Graf James A
10% Owner
290,603 $0 11,790,441
(Direct)
View
2024-12-06
Option Award
2024-12-10
9:56 pm
N/A
2034-12-06
NKGen Biotech Inc. NKGN Scott Kathleen D.
Director
800,000 $0 800,000
(Direct)
View
2024-12-06
Option Award
2024-12-10
9:56 pm
N/A
2034-12-06
NKGen Biotech Inc. NKGN Klowden Michael
Director
800,000 $0 800,000
(Direct)
View
2024-12-06
Option Award
2024-12-10
9:56 pm
N/A
2034-12-06
NKGen Biotech Inc. NKGN Song Paul Y.
Chief Executive Officer
2,000,000 $0 2,000,000
(Direct)
View
2024-12-06
Option Award
2024-12-10
9:55 pm
N/A
2034-12-06
NKGen Biotech Inc. NKGN Graf James A
Chief Financial Officer
500,000 $0 500,000
(Direct)
View

Ownership
2024-08-27
6:45 pm
N/A
N/A
NKGen Biotech Inc. NKGN CFIC-2015 NV Family Investments LLC
Cherng Andrew Jin-Chan
CHERNG PEGGY
10% Owner
0 $0 8,291,666
(Indirect)
View
2024-07-11
Option Award
2024-07-18
5:53 pm
N/A
N/A
NKGen Biotech Inc. NKGN Gottardis Marco
Director
300,000 $0 16,667
(Direct)
View

Ownership
2024-07-18
5:52 pm
N/A
N/A
NKGen Biotech Inc. NKGN Gottardis Marco
Director
0 $0 300,000
(Direct)
View
2024-02-12
Option Award
2024-02-14
8:20 pm
N/A
N/A
NKGen Biotech Inc. NKGN Scott Kathleen D.
Director
300,000 $0 300,000
(Direct)
View
2024-02-12
Option Award
2024-02-14
8:19 pm
N/A
N/A
NKGen Biotech Inc. NKGN Kim Yong Man
CSO and CIO
75,000 $0 75,000
(Direct)
View
2024-02-12
Option Award
2024-02-14
8:16 pm
N/A
N/A
NKGen Biotech Inc. NKGN Song Paul Y.
Chief Executive Officer
1,260,000 $0 1,260,000
(Direct)
View
2024-02-12
Option Award
2024-02-14
8:14 pm
N/A
N/A
NKGen Biotech Inc. NKGN Gagnon Pierre
Chief Operating Officer
360,000 $0 360,000
(Direct)
View
2024-02-12
Option Award
2024-02-14
8:11 pm
N/A
N/A
NKGen Biotech Inc. NKGN Klowden Michael
Director
300,000 $0 300,000
(Direct)
View
2023-12-13
Gift
2023-12-15
9:02 pm
N/A
N/A
NKGen Biotech Inc. NKGN Park Sangwoo
NKMAX Co. Ltd.
See Remarks
10% Owner
2,500,000 $0 10,517,990
(Indirect)
View

Ownership
2023-10-10
4:11 pm
N/A
2029-10-22
NKGen Biotech Inc. NKGN Gagnon Pierre
Chief Operating Officer
0 $0 161,834
(Direct)
View

Ownership
2023-10-10
4:10 pm
N/A
N/A
NKGen Biotech Inc. NKGN Kim Yong Man
CSO and CIO
0 $0 161,834
(Direct)
View

Ownership
2023-10-10
4:06 pm
N/A
N/A
NKGen Biotech Inc. NKGN Song Paul Y.
Chief Executive Officer
0 $0 647,339
(Direct)
View

Ownership
2023-10-10
4:04 pm
N/A
N/A
NKGen Biotech Inc. NKGN Park Sangwoo
NKMAX Co. Ltd.
See Remarks
10% Owner
0 $0 15,753,457
(Indirect)
View
2023-09-29
Option Award
2023-10-04
06:10 am
2023-10-29
2028-09-29
NKGen Biotech Inc. NKGN Graf Acquisition Partners IV LLC
Graf James A
10% Owner
5,244,673 $1.5 14,176,581
(Direct)
View
2023-09-29
Other
2023-10-04
06:10 am
N/A
N/A
NKGen Biotech Inc. NKGN Graf Acquisition Partners IV LLC
Graf James A
10% Owner
1,773,631 $0 14,176,581
(Direct)
View
2021-07-14
Other
2021-07-14
4:54 pm
N/A
N/A
Graf Acquisition Corp. IV GFOR Graf Acquisition Partners IV LLC
Graf James A
Chief Executive Officer
10% Owner
20,000 $0 4,230,375
(Direct)
View

Ownership
2021-07-14
4:53 pm
N/A
N/A
Graf Acquisition Corp. IV GFOR LEBENTHAL ALEXANDRA
Director
0 $0 20,000
(Direct)
View
2021-06-02
Other
2021-06-02
5:13 pm
N/A
N/A
Graf Acquisition Corp. IV GFOR Graf Acquisition Partners IV LLC
Graf James A
Chief Executive Officer
10% Owner
22,125 $0 4,252,500
(Direct)
View

Ownership
2021-05-20
7:25 pm
N/A
N/A
Graf Acquisition Corp. IV GFOR Cruz Anatolio B III
Director
0 $0 20,000
(Direct)
View
Goto 0, 1, Next